SynthesisEndocrine2025
Efficacy and safety of iGlarLixi versus insulin glargine in type 2 diabetes: a meta-analysis of randomized controlled trials.
Jingxin Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it